PD

Pro-Dex IncNASDAQ PDEX Stock Report

Last reporting period 30 Jun, 2024

Updated 14 Nov, 2024

Last price

Market cap $B

0.089

Micro

Exchange

XNAS - Nasdaq

PDEX Stock Analysis

PD

Avoid

Based on Eyestock quantitative analysis, PDEX`s fundamental data and valuation indicate an investment grade of Avoid at the current time.

Rating

To assess the quality of a company's business, we have collected all financial data from the statements and presented them in the form of a single number - the company's rating. Rating value of 100 is the threshold for determining a viable investment.

48/100

Low score

Upside

To determine whether the current price is a reasonable to buy a stock, we compare it to our estimate of fair value. The more undervalued a stock is, the higher the upside.

-81.9 %

Greatly overvalued

Market cap $B

0.089

Dividend yield

Shares outstanding

3.544 B

Pro-Dex, Inc. engages in the design, development and manufacture of rotary drive surgical and dental instruments. The company is headquartered in Irvine, California and currently employs 135 full-time employees. The firm also manufactures and sells rotary air motors to a wide range of industries. The firm manufactures surgical implantable, devices with electronics, custom software development, complex assemblies and sub-assemblies, sterilization, complex materials, and injection molding. The Company’s products include finished medical devices, micro air-motors, adaptive torque limiting, powered surgical drivers, and precision air powered motors. The firm's medical device products are sold primarily to original equipment manufacturers and air motors are sold primarily to a range of distributors and end users. The firm serves a range of industries including aerospace, automotive, industrial, communications, dental, oil and gas, healthcare, robotics, and research.

View Section: Eyestock Rating